Neumora Therapeutics, Inc. NMRA Q2 2025 earnings

FAQ

When did Neumora Therapeutics, Inc. report Q2 2025 earnings?

Neumora Therapeutics, Inc. (NMRA) reported Q2 2025 earnings on August 6, 2025 after market close.

What were Neumora Therapeutics, Inc.'s Q2 2025 revenue and EPS?

Neumora Therapeutics, Inc. reported eps of $-0.33 for Q2 2025.

Did Neumora Therapeutics, Inc. beat estimates in Q2 2025?

EPS beat the consensus estimate of $-0.38 by $0.05.

How did Neumora Therapeutics, Inc.'s Q2 2025 results compare year-over-year?

Compared to the same quarter a year prior, eps grew 10.8% from $-0.37.

Where can I find Neumora Therapeutics, Inc.'s Q2 2025 SEC filings?

You can read the 8-K earnings release (0000950170-25-103997) and the 10-Q periodic report (0000950170-25-104138) directly on SEC EDGAR. The filing index links above go to sec.gov.